-
cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
January 01, 2016 - outlines treatments based on LDL levels)
· CMS 64 – LDL Risk Stratified Cholesterol (since it centers on treating … outlines treatments based on LDL levels)
· CMS 64 – LDL Risk Stratified Cholesterol (since it centers on treating
-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_WG_February_2022_Summary.pdf
January 01, 2022 - healthcare solutions to leverage technologies and remove
barriers to their impactful use in effectively treating
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - CVD can include CHF in some interpretations and statins are not as effective at treating heart failure
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-09/Wells%20Criteria.txt
January 01, 2023 - Wells Criteria - Derivation of a simple clinical model to categorize patientsÕ probability of pulmonary embolism.
Rules
1. IF [Wells score >4] THEN [CTPE]
2. IF [Wells Score <=4] AND [D-dimer normal] THEN NOT [CTPE]
3. IF [Wells score <=4] AND [D-Dimer elevated] THEN [CTPE]
Additional Values (Wells score)
- Clinical…
-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - Osteoporosis Patient Handout
Bisphosphonates are the safest choice for most people like you, who have thin
or fragile bones, because this risks of falling and breaking a bone are greater
than the risks of side effects.
Your medication is: _______________________________________
Orally (by mouth)
I.V. (infusion)
D…
-
cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - Osteoporosis Patient Handout
Bisphosphonates are the safest choice for most people like you, who have thin
or fragile bones, because this risks of falling and breaking a bone are greater
than the risks of side effects.
Your medication is: _______________________________________
Orally (by mouth)
I.V. (infusion)
D…
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
02/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Welcome
· Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment Details
· Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
· Discuss Next Artifacts for Developmen…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - CDS artifact compiles and displays available and relevant information for the care
team to use when treating … exploration in turn depends on them developing informed preferences.7
Use of Summaries to Facilitate Care
Treating … Nonopioid pain
medication”
Medications with analgesic effects that may provide therapeutic benefit in treating
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - Using Electronic Health Records and Clinical Decision Support to Provide Guidance on
Occupational Factors which Impact Diabetes: A Final Knowledge Resource Report
Revised and resubmitted December 4, 2015
The Diabetes subject matter expert (SME) group
Convened by the Association of Occupational and Environmenta…
-
cds.ahrq.gov/taxonomy/term/30781
July 30, 2021 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Shared
Decision Making
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ah…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April 2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Updated 10-
Year ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD…
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document.
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared for:
Agency for Healthcare Re…
-
cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
01/11/2017
Time
3:00 – 5:00 PM ET
AGENDA
· Welcome and introductions
· Discuss ACC/AHA 10-Year ASCVD Risk Assessment Tool Metadata and CDS creation
· Discuss Longitudinal Risk Assessment Tool Metadata, CDS Creation and Shared Decision Making
· Questions to…
-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
April 21, 2022
3:00 – 4:00 pm ET
Attendees: 31 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3)
WG Members Alex Go…
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal ASCVD
Risk Assessment Tool for Baseline 10-Year
ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857 …
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Baseline 10-
Year ASCVD Risk
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/taxonomy/term/23721
August 06, 2020 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - excretion,
polypharmacy, and multiple co-morbidities” and “there does not appear to be a
benefit to treating … There does not appear to be a benefit to treating people on chronic dialysis, likely due to
excessive